drugset / Trial / NCT05627921

The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients

NCT05627921

Unknown 40 enrolled Marmara University
RandomizedParallel-groupDouble-blindTreatment

Summary

Cerebral Palsy (CP) is a group of movement and posture disorders associated with a non-progressive affect during brain development that can cause limitation of activity and disability. The most common movement disorders in CP are spasticity and dystonia. Currently, the treatment of muscle stiffness called spasticity includes physiotherapy, casting and device, various drugs and surgical treatment. Botulinum toxin injection into the muscle also acts by reducing muscle contraction. ESWT is a method used in various musculoskeletal diseases. It has been previously applied to pediatric patients and has been shown to be effective and painless in ankle muscle stiffness. However, there are few studies investigating the effect of ESWT on functionality.

Timeline

Start
2022-11-15
Primary completion
2023-07-15
Completion
2023-07-15

Drugs

EvaluationDrugModalityDoseRoute
Background Botulinum toxin type A Protein / enzyme biologic Intramuscular